For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) appeared to offer better prevention of stroke and thromboembolic events ...
Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.